YIH
OMGA

Y-Intercept (HK)’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Y-Intercept (HK)’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-77,417
Closed -$160K – 1908
2024
Q2 		$160K Buy
+77,417
New +$182K 0.01% 1206
2023
Q2 		– Sell
-16,227
Closed -$97.8K – 1810
2023
Q1 		$97.8K Buy
+16,227
New +$113K 0.01% 1058

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Y-Intercept (HK)'s OMGA Position: Q3 2024 in Review

Y-Intercept (HK) sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q3 2024, closing a stake of 77,417 shares — an estimated $160K sold.

Y-Intercept (HK) first reported a position in OMGA in Q1 2023 and held it in 2 quarters. The position peaked at $160K in Q2 2024. 54 funds tracked by Wall St. Rank hold OMGA as of Q3 2024.

  • Y-Intercept (HK) reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 77,417 Omega Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $160K.
  • Y-Intercept (HK) first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Y-Intercept (HK)'s Omega Therapeutics, Inc. Common Stock position peaked at $160K in Q2 2024.
  • 54 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.